CD47 and ovarian cancer: A revolutionary advancement in immune-oncology research, CAR-T cell treatments were applied in the CD47 blockade arena, with studies showing tumor killing against lung, ovarian and pancreatic cell lines, as well as the blocking of pancreatic and ovarian cancer xenograft growth in vivo [116,117,118].